(Q54586024)
Statements
Nilotinib treatment-associated peripheral artery disease and sudden death: yet another reason to stick to imatinib as front-line therapy for chronic myelogenous leukemia. (English)
Ayalew Tefferi
1 reference
Louis Letendre
31 May 2011
86
7
610-611